ArticleMolecular therapy. Methods & clinical development2023

CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa.

Xianqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.